Shalini V Mohan Karen Y Kuo Anne Lynn S Chang
10.1016/j.jdcr.2015.11.007
JAAD Case Rep
2016 Jan 8;2(1):13-5.
bcc, basal cell carcinoma ctla4, cytotoxic t-lymphocyte–associated 4 mri, magnetic resonance imaging basal cell carcinoma immunotherapy ipilimumab melanoma regression solid tumor vismodegib
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/27051815/
Case Reports
PMC4809440
27051815
Incidental regression of an advanced basal cell carcinoma after ipilimumab exposure for metastatic melanoma
2016